Clinical Trials Directory

Trials / Unknown

UnknownNCT05670548

Early Prediction of Postpartum Glucose Metabolism Abnormalities in Gestational Diabetes Mellitus

Early Prediction of Postpartum Glucose Metabolism Abnormalities in Gestational Diabetes Mellitus Based on Gestational Metabolic Profile and Lipid Profile

Status
Unknown
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Women's Hospital School Of Medicine Zhejiang University · Academic / Other
Sex
Female
Age
20 Years – 49 Years
Healthy volunteers
Accepted

Summary

This project is expected to screen reliable serum markers in pregnant women with gestational diabetes mellitus (GDM) by using metabolic profiling and lipid profiling clinical high-throughput mass spectrometry technology. We intend to build an early pregnancy prediction model for postpartum glucose metabolism abnormalities of GDM. At the same time, this project plans to develop a predictive management system based on this model, so that it can be widely used in clinical detection process, realize the advance of the early warning window period of abnormal glucose metabolism, and provide theoretical guidance for the early postpartum blocking of GDM to the outcome of abnormal glucose metabolism.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaire survey and specimen collectionA questionnaire survey was conducted when pregnant women were enrolled, and blood were collected at 24-28 gestational weeks. Placenta and umbilical cord blood are collected during delivery.

Timeline

Start date
2023-01-01
Primary completion
2023-12-31
Completion
2025-12-31
First posted
2023-01-04
Last updated
2023-01-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05670548. Inclusion in this directory is not an endorsement.